{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:29:53Z","timestamp":1787585393775,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003191","name":"R\u00e9gion Normandie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.nbd.2026.107505","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T15:21:59Z","timestamp":1782400919000},"page":"107505","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Structural remodeling of tumor microtubes in IDH1 mutation shapes microRNA transfer in glioma"],"prefix":"10.1016","volume":"227","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7373-1109","authenticated-orcid":false,"given":"Arthur","family":"Leclerc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Levallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magalie","family":"B\u00e9nard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"Galas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9velyne","family":"Emery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gu\u00e9na\u00eblle","family":"Levallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2026.107505_bb0005","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1073\/pnas.1019055108","article-title":"Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma","volume":"108","author":"Arroyo","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2026.107505_bb0010","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1158\/2159-8290.CD-24-0414","article-title":"Screening for tumor microtube-targeting drugs identifies PKC modulators as multipotent inhibitors of glioblastoma progression","volume":"16","author":"Azor\u00edn","year":"2026","journal-title":"Cancer Discov."},{"key":"10.1016\/j.nbd.2026.107505_bb0015","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1997","article-title":"MicroRNA signatures in human cancers","volume":"6","author":"Calin","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.nbd.2026.107505_bb0020","doi-asserted-by":"crossref","first-page":"6029","DOI":"10.1158\/0008-5472.CAN-05-0137","article-title":"MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells","volume":"65","author":"Chan","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.nbd.2026.107505_bb0025","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nature08617","article-title":"Cancer-associated IDH1 mutations produce 2-hydroxyglutarate","volume":"462","author":"Dang","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2026.107505_bb0030","doi-asserted-by":"crossref","first-page":"5369","DOI":"10.1128\/MCB.00479-08","article-title":"MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators","volume":"28","author":"Gabriely","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.nbd.2026.107505_bb0035","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/jnen\/nlae119","article-title":"Tumor microtubes: a new potential therapeutic target for high-grade gliomas","volume":"84","author":"Guo","year":"2025","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2026.107505_bb0040","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41586-022-05520-4","article-title":"Autonomous rhythmic activity in glioma networks drives brain tumour growth","volume":"613","author":"Hausmann","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2026.107505_bb0045","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.molmed.2014.06.005","article-title":"MicroRNAs in cancer: biomarkers, functions and therapy","volume":"20","author":"Hayes","year":"2014","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.nbd.2026.107505_bb0050","doi-asserted-by":"crossref","first-page":"9257","DOI":"10.18632\/oncotarget.3288","article-title":"miR-340 suppresses glioblastoma multiforme","volume":"6","author":"Huang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.nbd.2026.107505_bb0055","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1038\/s41598-023-29298-1","article-title":"Impact of GAP-43, Cx43 and actin expression on the outcome and overall survival in diffuse and anaplastic gliomas","volume":"13","author":"Krigers","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2026.107505_bb0060","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.ymthe.2016.11.016","article-title":"RNA nanoparticle-based targeted therapy for glioblastoma through inhibition of oncogenic miR-21","volume":"25","author":"Lee","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2026.107505_bb0065","article-title":"Anti-miR21-conjugated DNA nanohydrogel for enhanced cancer therapy","volume":"169","author":"Lee","year":"2024","journal-title":"Biomater. Adv."},{"key":"10.1016\/j.nbd.2026.107505_bb0070","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.bbrc.2015.03.088","article-title":"miR-340 inhibits glioblastoma cell proliferation by suppressing CDK6, cyclin-D1 and cyclin-D2","volume":"460","author":"Li","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.nbd.2026.107505_bb0075","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.2147\/CMAR.S250772","article-title":"Upregulation of miR-340 inhibits tumor growth and mesenchymal transition via targeting c-MET in glioblastoma","volume":"12","author":"Lin","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.nbd.2026.107505_bb0080","article-title":"Tunneling nanotubes and tumor microtubes \u2014 emerging data on their roles in intercellular communication and pathophysiology","volume":"38","author":"Lou","year":"2024","journal-title":"FASEB J."},{"key":"10.1016\/j.nbd.2026.107505_bb0085","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2026.107505_bb0090","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/clpt.2012.192","article-title":"Clinical applications for microRNAs in cancer","volume":"93","author":"Nana-Sinkam","year":"2013","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.nbd.2026.107505_bb0095","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nature16071","article-title":"Brain tumour cells interconnect to a functional and resistant network","volume":"528","author":"Osswald","year":"2015","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.nbd.2026.107505_bb0100","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011\u20132015","volume":"20","author":"Ostrom","year":"2018","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.nbd.2026.107505_bb0105","doi-asserted-by":"crossref","first-page":"8164","DOI":"10.1158\/0008-5472.CAN-08-1305","article-title":"MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells","volume":"68","author":"Papagiannakopoulos","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.nbd.2026.107505_bb0110","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2026.107505_bb0115","doi-asserted-by":"crossref","first-page":"9211","DOI":"10.1158\/0008-5472.CAN-09-1622","article-title":"EZH2 is essential for glioblastoma cancer stem cell maintenance","volume":"69","author":"Suv\u00e0","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.nbd.2026.107505_bb0120","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nature10866","article-title":"IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype","volume":"483","author":"Turcan","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2026.107505_bb0125","doi-asserted-by":"crossref","first-page":"7223","DOI":"10.1093\/nar\/gkr254","article-title":"Characterization of extracellular circulating microRNA","volume":"39","author":"Turchinovich","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.nbd.2026.107505_bb0130","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41586-019-1564-x","article-title":"Glutamatergic synaptic input to glioma cells drives brain tumour progression","volume":"573","author":"Venkataramani","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2026.107505_bb0135","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nature24014","article-title":"Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma","volume":"549","author":"Venkatesh","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2026.107505_bb0140","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/ncb2210","article-title":"MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins","volume":"13","author":"Vickers","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.nbd.2026.107505_bb0145","article-title":"IDH1(R132H) mutation increases U87 glioma cell sensitivity to radiation therapy in hypoxia","volume":"2014","author":"Wang","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.nbd.2026.107505_bb0150","article-title":"The network of tumor microtubes: an improperly reactivated neural cell network with stemness feature for resistance and recurrence in gliomas","volume":"12","author":"Wang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.nbd.2026.107505_bb0155","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/neuonc\/nox070","article-title":"Tumor microtubes convey resistance to surgical lesions and chemotherapy in gliomas","volume":"19","author":"Weil","year":"2017","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.nbd.2026.107505_bb0160","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1126\/science.aar5555","article-title":"Harmful networks in the brain and beyond","volume":"359","author":"Winkler","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.nbd.2026.107505_bb0165","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.cell.2023.02.002","article-title":"Cancer neuroscience: state of the field, emerging directions","volume":"186","author":"Winkler","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2026.107505_bb0170","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"360","author":"Yan","year":"2009","journal-title":"N. Engl. J. Med."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996126002500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996126002500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:56:09Z","timestamp":1787583369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996126002500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":34,"alternative-id":["S0969996126002500"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2026.107505","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural remodeling of tumor microtubes in IDH1 mutation shapes microRNA transfer in glioma","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2026.107505","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107505"}}